NCT03577197Recruiting
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
Southeast Netherlands Advanced Breast Cancer Registry
Source: ClinicalTrials.gov · Last updated 23 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of 2007 in 11 hospitals in the Netherlands. Data on patient, tumor and treatment characteristics are collected retrospectively from electronic medical files by trained registry clerks.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 7000 (estimated)
- First submitted
- 11 Jun 2018
- Start date
- 1 Jan 2007
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Academisch Ziekenhuis Maastricht
- Diseases
- Metastatic breast cancer
- NCT number
- NCT03577197
What you commit to
- Study type: Observational
- Planned participants: 7000
- From 1 Jan 2007 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Diagnosed with de novo or recurrent advanced breast cancer since 2007
- Diagnosed with or treated for advanced breast cancer in one of the participating hospitals
- Participating hospitals (period of inclusion): Maastricht UMC+ (2007-2025), Zuyderland hospitals Sittard/Heerlen (2007-2025), Amphia Hospital Breda (2013-2025), Catharina Hospital Eindhoven (2007-2025), Elkerliek Hospital Helmond (2010-2025), Maxima Medical Center Veldhoven/Eindhoven (2007-2025), Jeroen Bosch Hospital Den Bosch (2013-2025), Laurentius Hospital Roermond (2007-2025), St. Annaziekenhuis Geldrop (2007-2025), St. Elisabeth Hospital Tilburg (2007-2009), St. Jans Gasthuis Weert (2007-2025), VieCuri Medical Center Venlo/Venray (2013-2025), all in the Netherlands.
- Hospitals (and periods) were eligible for inclusion if (distant) registration from Maastricht UMC+ was possible.
- The inclusion period may be prolonged after 2025.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Multiple hospitals in the Netherlands (see Eligibility) Coordinator of this site? Confirm its status | Maastricht | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.